Badar, Talha
Mayo Clinic in Florida
3 papers on CoChatORCID 0000-0003-1548-918X
Most cited papers
- Verified
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Badar, T., Nanaa, A., Atallah, E., Shallis, R. M., Guilherme, S. D. C. C., Goldberg, A. D., Saliba, A. N., Patel, A., Bewersdorf, J. P., DuVall, A. S., et al. (2024) · Blood Cancer Journal
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 33
- Verified
Chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia.
Badar, T., & Shah, N. N. (2020) · Current Treatment Options in Oncology
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 27
- Verified
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
Shah, M. V., Hung, K., Baranwal, A., Kutyna, M. M., Al-Kali, A., Toop, C., Greipp, P., Brown, A., Shah, S., Khanna, S., et al. (2025) · Blood Advances
Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free